S5 Ep23: Wainberg Weighs In on Advances in HER2+ GI Cancers
OncLive® On Air - Podcast készítő OncLive® On Air
In our exclusive interview, Wainberg discussed factors that help steer treatment selection in HER2-positive gastrointestinal malignancies, advances on the horizon, and more!
